NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Agency / Source: Yokogawa Electric Corporation

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Yokogawa Introduces CellVoyager High-Content Analysis System CQ3000 - For greater efficiency in drug discovery and regenerative medicine R&D, and the swift commercialization of new drugs - Yokogawa.com
Yokogawa Introduces CellVoyager High-Content Analysis System CQ3000

 

NewswireTODAY - /newswire/ - Tokyo, Japan, 2024/01/31 - For greater efficiency in drug discovery and regenerative medicine R&D, and the swift commercialization of new drugs - Yokogawa.com. TOKYO: 6841

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Yokogawa Electric Corporation announces the development of the CellVoyager High-Content Analysis System CQ3000 as part of the CellVoyager™ high-content analysis (HCA) system solution lineup, which includes cell observation devices and image analysis software. This product is scheduled to go on sale in July 2024.

The CQ3000 can capture high-definition 3D microscopic images of live cell cultures at high speeds. When used together with the CellPathfinder image analysis software, it can quantify and analyze intracellular organelles to assess cellular reactions and the effects of drug compounds. It enables the highly efficient assessment of cells in a wide range of settings, from basic research to drug discovery screening.

The CQ3000 will be exhibited at SLAS2024, an international conference and exhibition hosted by the Society for Laboratory Automation and Screening (SLAS) that will be held February 3-7 in Boston.

Development Background

HCA systems are widely used in new drug discovery to identify promising chemical responses by screening entire libraries of candidate compounds. In recent years, there has been a rising demand for advanced, high-speed screening systems that can extract and analyze large volumes of data from high-definition cell images using conventional image processing and deep learning. There is also an increasing need to speed up the new drug discovery process by automating and accelerating screening operations.

Main Features

This CellVoyager product is a mid-range HCA system that enables high-resolution live cell imaging in the same way as the CellVoyager CQ1 benchtop high-content analysis system and the CellVoyager CV8000 high-throughput cytological discovery system. This new model will give users a wider range of choices in applications ranging from basic research to large-scale screening and can be offered in combination with products such as the CellPathfinder high-content analysis software to provide solutions that suit every requirement and budget.

1. High-definition observation of living cells over long time periods
The CQ3000 enables the stable and precise observation of live cell cultures over long time periods thanks to Yokogawa's high-precision temperature control and dual spinning-disk with microlens that captures optical slice images (confocal images) with higher speed and better sensitivity, which minimizes damage to cells compared to other confocal systems on the market.

2. High speed screening
The CQ3000 can capture images of microplates at high speed due to enhancements in the stage control and auto-focus functions. When used in combination with the optional dual camera and wide-field image capture features, which uniformly captures the entire field of view, image capture time is reduced. This product enables the high-speed selection of promising chemical compounds from vast numbers of new drug candidates.

3. High image quality
By using Yokogawa's proprietary water immersion lens mechanism, in addition to detailed observation at high magnification levels, it is also possible to capture bright images at low magnification levels. The use of an optional uniformizer achieves even illumination across the entire field of view, for the capture of vivid images.

Hiroshi Nakao, a Yokogawa vice president and head of the company's Life Business Headquarters, says,“The CQ3000 is an enhancement to the CellVoyager series lineup that will accelerate the development of new drugs and streamline basic research in cutting-edge biology and medicine. Through the provision of products and solutions that contribute to drug discovery research and the advancement of individualized medicine and regenerative medicine, Yokogawa aims to ensure well-being and quality of life for all.”

Major Target Markets

Pharmaceuticals, medical and biological research

Applications

• Drug discovery;
• Regenerative medicine research;
• Basic research in fields such as medicine, pathology, anatomy, and biology.

About CellVoyager

CellVoyager is Yokogawa's HCA system solution. To suit customers' requirements, optimum solutions that combine cell observation devices (CV8000, CQ1, CQ3000) and image analysis software (CellPathfinder) can be provided.

These HCA systems enable high-speed screening and are comprised of a confocal scanner unit for the real-time observation of living cells and a drive mechanism for the high-speed observation of large numbers of samples that was developed based on precision positioning technology originally used on semiconductor and LCD production lines. Their high-speed screening, high resolution, and ability to capture images as chemical compounds are administered (for the observations of changes to cells) are highly regarded, and they have helped to accelerate the development of new drugs and streamline basic research processes in cutting edge biology and medical fields.

About Yokogawa

Yokogawa (yokogawa.com) provides advanced solutions in the areas of measurement, control, and information to customers across a broad range of industries, including energy, chemicals, materials, pharmaceuticals, and food. Yokogawa addresses customer issues regarding the optimization of production, assets, and the supply chain with the effective application of digital technologies, enabling the transition to autonomous operations.

Founded in Tokyo in 1915, Yokogawa continues to work toward a sustainable society through its 17,000+ employees in a global network of 129 companies spanning 60 countries.

The names of corporations, organizations, products, services, and logos herein are either registered trademarks or trademarks of Yokogawa Electric Corporation or their respective holders.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Yokogawa Electric Corporation

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services / Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Yokogawa Introduces CellVoyager High-Content Analysis System CQ3000

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
CellVoyager | Yokogawa Electric Corp.
Contact: Press Office - Yokogawa.com 
+81 422-52-5535 press[.]yokogawa.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Yokogawa Electric Corporation securities in any jurisdiction including any other companies listed or named in this release.

Medical Services / Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Yokogawa Electric Corporation / Company Profile


Read Medical Services / Equipment Most Recent Related Newswires:

Bruker's Canopy Biosciences Announces the Launch of CellScape™ Whole-Slide Imaging Chamber for Spatial Biology
iSono Health Applauded by Frost & Sullivan for Ensuring Patient Comfort and Safety Providing Quality Imaging & Diagnosis with its iSono Health ATUSA
Bruker Launches the New BEAM, a Dedicated Single-Point FT-NIR Spectrometer Designed for In-Process Control
Bruker Introduces the Ingenious Novel ‘Triceratops’ SPR #64 Surface Plasmon Resonance System for Drug Discovery At SLAS2024
Advantech Introduces Cutting-Edge Solutions to Address Diverse Imaging Needs in Operating Rooms - The AVAS-2 Series for 4K Streaming Excellence
Seno Medical Earns Frost & Sullivan’s 2023 United States Enabling Technology Leadership Award for Delivering a More Efficient Breast Cancer Diagnosis
Withings Announces BeamO The Revolutionary At-home Health Checkup
Advancing GLP-1 Treatments, Insulin, and Large-volume Injections with Ready-to-use Cartridges from SCHOTT Pharma
Sofwave Earns Frost & Sullivan’s 2023 NA Technology Innovation Leadership Award for Developing A Sophisticated Skin Tightening Ultrasound Technology
Frost & Sullivan Recognizes Neuromod Devices with the New Product Innovation Award for Developing Robust Solution that Meets Tinnitus Patients’ Needs
Clarius Applauded by Frost & Sullivan with the Company of the Year Award for its Handheld Ultrasound Systems and Market-leading Position
LyondellBasell Awarded the 2023 Global Medical Plastics Company of the Year by Frost & Sullivan
Avance Clinical Earns Frost 2023 Best Practices Customer Value Leadership Award for Delivering Clinical Trials Based on Globally Accepted Data
Bruker Launches timsTOF Ultra Mass Spectrometer with Transformative Sensitivity, 300Hz PASEF MS/MS & VistaScan for Enhanced dia-PASEF® 4D-Proteomics
Bruker Introduces Next-Generation Automated BioAFM for Quantification of Molecular Forces

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Limelon Advertising, Co.

Visit  BizJobs.com





 
  ©2005-2024 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)